Form UPLOAD - SEC-generated letter:
SEC Accession No. 0000000000-23-011405
Filing Date
2023-10-18
Accepted
2023-10-18 18:36:06
Documents
2

Document Format Files

Seq Description Document Type Size
1 filename1.pdf LETTER 36159
2 filename2.txt TEXT-EXTRACT 14756
  Complete submission text file 0000000000-23-011405.txt   65321
Mailing Address 18 CAMPUS BLVD. SUITE 100 NEWTOWN SQUARE PA 19073-3269
Business Address 18 CAMPUS BLVD. SUITE 100 NEWTOWN SQUARE PA 19073-3269 240-780-6356
ArriVent Biopharma, Inc. (Filed for) CIK: 0001868279 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: UPLOAD | File No.: 377-06842
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)